Ainhoa Oguiza

592 total citations
13 papers, 507 citations indexed

About

Ainhoa Oguiza is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ainhoa Oguiza has authored 13 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Ainhoa Oguiza's work include Atherosclerosis and Cardiovascular Diseases (6 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Ainhoa Oguiza is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (6 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Ainhoa Oguiza collaborates with scholars based in Spain, United States and Germany. Ainhoa Oguiza's co-authors include Jesús Egido, Carlota Recio, Carmen Gómez‐Guerrero, Iolanda Lázaro, Beñat Mallavia, Julia Blanco, Laura Lopez‐Sanz, Guadalupe Ortiz-Muñoz, Óscar López‐Franco and Julio Madrigal‐Matute and has published in prestigious journals such as PLoS ONE, Diabetes and Journal of the American Society of Nephrology.

In The Last Decade

Ainhoa Oguiza

13 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ainhoa Oguiza Spain 11 212 187 92 70 61 13 507
Virginia López-Parra Spain 8 160 0.8× 259 1.4× 116 1.3× 81 1.2× 73 1.2× 8 549
Yuexian Zhou China 10 151 0.7× 81 0.4× 104 1.1× 66 0.9× 40 0.7× 12 418
Ziyu Meng China 14 281 1.3× 86 0.5× 86 0.9× 76 1.1× 131 2.1× 35 671
Yitao Ou China 13 300 1.4× 121 0.6× 40 0.4× 57 0.8× 145 2.4× 19 603
Yoshinori Tsuchiyama Japan 8 235 1.1× 92 0.5× 51 0.6× 50 0.7× 85 1.4× 12 576
Xiaolan Yi United States 6 297 1.4× 76 0.4× 75 0.8× 38 0.5× 46 0.8× 7 537
Markus Latta Denmark 13 228 1.1× 134 0.7× 56 0.6× 17 0.2× 103 1.7× 23 556
Duy T. Nguyen United States 9 138 0.7× 96 0.5× 24 0.3× 123 1.8× 48 0.8× 9 381
Fuxu Wang China 11 264 1.2× 77 0.4× 89 1.0× 18 0.3× 35 0.6× 47 463

Countries citing papers authored by Ainhoa Oguiza

Since Specialization
Citations

This map shows the geographic impact of Ainhoa Oguiza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ainhoa Oguiza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ainhoa Oguiza more than expected).

Fields of papers citing papers by Ainhoa Oguiza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ainhoa Oguiza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ainhoa Oguiza. The network helps show where Ainhoa Oguiza may publish in the future.

Co-authorship network of co-authors of Ainhoa Oguiza

This figure shows the co-authorship network connecting the top 25 collaborators of Ainhoa Oguiza. A scholar is included among the top collaborators of Ainhoa Oguiza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ainhoa Oguiza. Ainhoa Oguiza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Burillo, Elena, Juan Vila, & Ainhoa Oguiza. (2021). Characteristics of patients with chronic hypoparathyroidism not adequately controlled with conventional treatment and management patterns in Spain. Endocrinología Diabetes y Nutrición (English ed ). 68(5). 304–311. 2 indexed citations
2.
Lázaro, Iolanda, Laura Lopez‐Sanz, Ainhoa Oguiza, et al.. (2018). Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms. Frontiers in Pharmacology. 9. 819–819. 62 indexed citations
3.
Lopez‐Sanz, Laura, Carlota Recio, Iolanda Lázaro, et al.. (2018). SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition. Laboratory Investigation. 98(10). 1276–1290. 43 indexed citations
4.
Lázaro, Iolanda, Ainhoa Oguiza, Carlota Recio, et al.. (2017). Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis. Clínica e Investigación en Arteriosclerosis. 29(2). 51–59. 24 indexed citations
5.
Recio, Carlota, Iolanda Lázaro, Ainhoa Oguiza, et al.. (2016). Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy. Journal of the American Society of Nephrology. 28(2). 575–585. 49 indexed citations
6.
Recio, Carlota, Ainhoa Oguiza, Beñat Mallavia, et al.. (2015). Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice. Basic Research in Cardiology. 110(2). 8–8. 37 indexed citations
7.
Lázaro, Iolanda, Ainhoa Oguiza, Carlota Recio, et al.. (2015). Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice. Diabetes. 64(10). 3600–3613. 74 indexed citations
8.
Oguiza, Ainhoa, Carlota Recio, Iolanda Lázaro, et al.. (2015). Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes. Diabetologia. 58(7). 1656–1667. 39 indexed citations
9.
Recio, Carlota, Ainhoa Oguiza, Iolanda Lázaro, et al.. (2014). Suppressor of Cytokine Signaling 1–Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(9). 1953–1960. 60 indexed citations
10.
Mallavia, Beñat, Carlota Recio, Ainhoa Oguiza, et al.. (2013). Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis. American Journal Of Pathology. 182(5). 1910–1921. 56 indexed citations
11.
Mallavia, Beñat, Ainhoa Oguiza, Óscar López‐Franco, et al.. (2013). Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice. PLoS ONE. 8(6). e66754–e66754. 23 indexed citations
12.
López-Parra, Virginia, Beñat Mallavia, Óscar López‐Franco, et al.. (2012). Fcγ Receptor Deficiency Attenuates Diabetic Nephropathy. Journal of the American Society of Nephrology. 23(9). 1518–1527. 37 indexed citations
13.
Oguiza, Ainhoa, et al.. (2003). Búsqueda de empleo en la CAPV (1993-1999): cualificación y género. Biblos-e Archivo (Universidad Autónoma de Madrid). 26(72). 233–257. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026